Smiling child

Our mission

An accessible treatment for every rare disease patient.

95% of rare diseases lack therapies. We identify new uses for existing drugs, delivering options for patients with urgent, unmet needs.

How we work

Identify repurposing opportunity

Prioritize rare indications where credible evidence could support a new therapeutic use.

Industry collaboration

Align with partners, clinicians, and advocates as the program takes shape.

Map regulatory pathway

Chart the route that fits the science via interactions, designations, and filings.

Seek approval

Work toward regulatory decisions with a clear, patient-grounded story.

Get in touch

For more information or to explore partnership, please contact us using our form or via email at info@kalevalatherapeutics.com

Open contact form